Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Scientific Prices €1.2B Senior Notes Offering

NEW YORK – Thermo Fisher Scientific said on Monday that it has priced an offering of €1.2 billion ($1.33 billion) worth of euro-denominated senior notes.

The Waltham, Massachusetts-based company is offering €6 billion worth of senior notes with an interest rate of 1.75 percent per year and a due date of 2027, and €6 billion worth of senior notes with an interest rate of 2.375 percent per year and a due date of 2032.

The offering is expected to close on or about April 2, subject to customary closing conditions, and the notes will pay interest on an annual basis.

Thermo Fisher plans to use the proceeds of the offering to pay in part for the $11.5 billion acquisition of Qiagen, expected to close in the first half of 2021, including paying back Qiagen's debt. It also intends to use the proceeds for general corporate purposes, such as the acquisition of companies, the repayment and refinancing of debt, working capital and capital expenditures, and the repurchase of outstanding equity securities.

JP Morgan Securities, Morgan Stanley International, Merrill Lynch International, and Citigroup Global are joint book-running managers for the offering, as well as Credit Suisse Securities (Europe), MUFG Securities EMEA, and US Bankcorp Investments for the 2027 notes, and BNP Paribas, HSBC Bank, and SMBC Nikko Capital Markets for the 2032 notes.

The new offering comes a week after Thermo Fisher offered a total of $2.2 billion worth of senior notes, due in 2025 and 2030.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.